Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections
RK Shields, DL Paterson… - Clinical Infectious …, 2023 - academic.oup.com
Carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRAB) is one of
the top-priority pathogens for new antibiotic development. Unlike other antibiotic-resistant …
the top-priority pathogens for new antibiotic development. Unlike other antibiotic-resistant …
Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery
Y Yang, YH Yan, CJ Schofield, A McNally, Z Zong… - Trends in …, 2023 - cell.com
Resistance to β-lactam antibiotics is rapidly growing, substantially due to the spread of
serine-β-lactamases (SBLs) and metallo-β-lactamases (MBLs), which efficiently catalyse β …
serine-β-lactamases (SBLs) and metallo-β-lactamases (MBLs), which efficiently catalyse β …
Serratia marcescens antibiotic resistance mechanisms of an opportunistic pathogen: a literature review
F Tavares-Carreon, K De Anda-Mora, IC Rojas-Barrera… - PeerJ, 2023 - peerj.com
Serratia marcescens is a ubiquitous bacterium from order Enterobacterales displaying a
high genetic plasticity that allows it to adapt and persist in multiple niches including soil …
high genetic plasticity that allows it to adapt and persist in multiple niches including soil …
Acinetobacter baumannii in the critically ill: complex infections get complicated
I Cavallo, A Oliva, R Pages, F Sivori, M Truglio… - Frontiers in …, 2023 - frontiersin.org
Acinetobacter baumannii is increasingly associated with various epidemics, representing a
serious concern due to the broad level of antimicrobial resistance and clinical …
serious concern due to the broad level of antimicrobial resistance and clinical …
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli
M Zeng, J Xia, Z Zong, Y Shi, Y Ni, F Hu, Y Chen… - Journal of Microbiology …, 2023 - Elsevier
The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …
[HTML][HTML] Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside
M Roch, R Sierra, DO Andrey - Clinical microbiology and infection, 2023 - Elsevier
Background Heteroresistance refers to subpopulation-mediated differential antimicrobial
susceptibility within a clonal bacterial population. Usually, it designates a resistant …
susceptibility within a clonal bacterial population. Usually, it designates a resistant …
Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care Unit
SM Smoke, A Brophy, S Reveron… - Clinical Infectious …, 2023 - academic.oup.com
We report on 11 critically ill burn patients treated with cefiderocol for carbapenem-resistant
Acinetobacter baumannii infections. Clinical success was achieved in 36% and complicated …
Acinetobacter baumannii infections. Clinical success was achieved in 36% and complicated …
[HTML][HTML] Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis
M Dadashi, B Hajikhani, N Nazarinejad… - Journal of Global …, 2023 - Elsevier
Objectives Stenotrophomonas maltophilia (S. maltophilia), an opportunistic pathogen,
causes infection in patients undergoing immunosuppressive therapy, mechanical …
causes infection in patients undergoing immunosuppressive therapy, mechanical …
Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence
P Viale, CE Sandrock, P Ramirez, GM Rossolini… - Annals of intensive …, 2023 - Springer
Appropriate antibiotic treatment for critically ill patients with serious Gram-negative infections
in the intensive care unit is crucial to minimize morbidity and mortality. Several new …
in the intensive care unit is crucial to minimize morbidity and mortality. Several new …
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with …
M Gatti, F Pea - Expert Review of Anti-infective Therapy, 2023 - Taylor & Francis
Introduction The choice of best therapeutic strategy for difficult-to-treat resistance (DTR)
Gram-negative infections currently represents an unmet clinical need. Areas covered This …
Gram-negative infections currently represents an unmet clinical need. Areas covered This …